The Transamerica IUL Lawsuit: What Happened and Why

What the Transamerica IUL Lawsuit Is About and Who Is Affected

The Transamerica IUL lawsuit centers on allegations that Transamerica used inflated policy illustrations, concealed fee structures, and misrepresented the long-term performance of its indexed universal life insurance products, specifically the Transamerica Financial Foundation IUL and the Transamerica Index Universal Life Insurance II. Policyholders claim the gap between illustrated projections and actual policy performance triggered unexpected premium increases and, in some cases, policy lapses.

This is not a retail consumer story. High-net-worth individuals who hold these policies inside Irrevocable Life Insurance Trusts (ILITs) for estate planning face the sharpest exposure. A lapsed ILIT-held policy does not just eliminate the death benefit. It can trigger gift tax consequences and unwind years of carefully constructed estate architecture.

Transamerica's parent company, Aegon (NYSE: AEG), is a publicly traded Dutch insurer required to disclose material litigation in its annual Form 20-F filings with the SEC. Those filings, not press coverage, are the authoritative record of litigation status, reserves set aside, and management's liability assessment. If you hold a Transamerica policy or Aegon equity, start there.

A Timeline of IUL Regulatory and Legal Milestones

Understanding the Transamerica IUL lawsuit requires context. The litigation did not emerge from a vacuum. It tracks a decade-long pattern of regulatory concern about how IUL products are illustrated and sold.

The 2020 NAIC AG 49-A rule change is the clearest regulatory admission that pre-2020 illustrations were problematic. If you purchased a Transamerica IUL before March 2020, your original illustrations were generated under the looser pre-AG 49-A standards. That is a concrete, verifiable basis for evaluating whether your policy was sold using projections regulators subsequently deemed misleading.

What the Allegations Against Transamerica's IUL Illustrations Actually Claim

The core allegation is straightforward: Transamerica showed prospective buyers illustrations projecting steady, index-linked growth while downplaying the structural features that cap that growth and the internal charges that erode it.

IUL policies credit interest based on index performance, but participation rates, annual caps, and spreads mean the policyholder never captures the full index return. The SEC has explicitly cautioned that these features can significantly erode projected returns relative to what illustrations suggest. Plaintiffs argue Transamerica's illustrations did not adequately model this erosion across realistic market scenarios.

The second allegation involves cost of insurance (COI) charges. Actuarial research from the Society of Actuaries confirms that COI charges within permanent life products escalate materially as policyholders age. Plaintiffs allege this escalation was not adequately disclosed at the point of sale, and that Transamerica subsequently increased COI rates in ways that accelerated cash value depletion.

The third allegation is breach of contract: that Transamerica modified policy terms without adequate notice, effectively changing the economics of existing policies after purchase.

Transamerica has denied these allegations, maintaining that fees and risks were disclosed in policy documents. That defense is not implausible on its face. IUL policy contracts are dense, and insurers routinely argue that disclosure buried in a prospectus satisfies their legal obligation. Whether courts agree is the central question still being litigated.

For a broader view of how these allegations compare across the industry, the broader IUL lawsuit landscape shows Transamerica is not the only carrier facing this scrutiny.

The Legal Mechanics: How This Case Got to Federal Court

Under the Class Action Fairness Act of 2005 (CAFA), 28 U.S.C. § 1332(d), federal courts have jurisdiction over class actions where the aggregate amount in controversy exceeds $5 million and minimal diversity exists between plaintiffs and defendants. A multi-state IUL class action against a major insurer clears that bar easily.

The court's decision to grant class-action status was a significant development. It means individual policyholders who could not economically justify solo litigation now have standing within a consolidated proceeding. For Transamerica, it substantially increases both the financial exposure and the reputational cost of fighting to verdict.

Key procedural developments so far include the court allowing fraud and breach of contract claims to proceed while dismissing certain other allegations. Discovery is expected to produce internal sales training materials, illustration software parameters, and actuarial assumptions. Those documents will be central to whether plaintiffs can demonstrate that Transamerica knew its illustrations were unrealistic.

The litigation timeline is long. Complex class actions of this type routinely run five to ten years from filing to resolution. Readers with existing policies should not wait for a verdict before auditing their own exposure.

Are IUL Policies a Good Investment for High-Net-Worth Individuals?

Honest answer: it depends entirely on structure, carrier, and purpose. The legitimacy concerns surrounding IUL policies are real, but blanket condemnation ignores the legitimate use cases.

For high-net-worth individuals, the relevant question is not whether IULs are good products in the abstract. It is whether a specific policy, with its specific cap rates, participation rates, COI schedule, and fee structure, achieves a defined goal more efficiently than alternatives.

Research published in the Journal of Financial Planning found that permanent life insurance products, including IULs, are frequently used by high-net-worth individuals for estate liquidity, but that complexity and cost opacity remain persistent concerns for advisors. That framing is accurate. The tax-free death benefit and tax-deferred cash value accumulation under IRC Section 7702 are genuine advantages. The problem is that those advantages can be negated by internal costs that were not transparently disclosed at purchase.

The specific risks for FatFIRE-level policyholders:

• ILIT lapse risk. If COI charges increase unexpectedly and the trust cannot fund additional premiums, the policy lapses. This eliminates the death benefit, potentially triggers gift tax consequences on prior premium transfers, and unwinds the estate planning structure entirely.
• IRC Section 7702 compliance. Policies that fail to maintain the required ratio of death benefit to cash value lose their tax-advantaged status. An underperforming policy that requires restructuring may create taxable events.
• Illustration reliance. If your purchase decision was driven primarily by an illustration generated before March 2020, the NAIC has effectively acknowledged that illustration may have been based on standards regulators deemed misleading.

Understanding universal life insurance interest rate mechanics is essential before drawing any conclusions about your specific policy's trajectory.

Hidden Fees in IUL Policies That Regulators Have Flagged

This is where the gap between illustration and reality is widest. IUL policies carry multiple layers of internal charges that compound over time.

FINRA's Regulatory Notice 16-32 specifically identifies that omission of material costs in complex product illustrations can constitute a violation of fair dealing obligations. The Transamerica plaintiffs are essentially arguing that the cumulative effect of these charges was material and was not adequately disclosed.

For any existing IUL policy, request an in-force illustration from the carrier showing current COI rates projected forward to age 85 and 90. Compare that to your original illustration. The divergence, if any, tells you your actual exposure.

Should High-Net-Worth Individuals Use IUL Policies for Estate Planning After This Lawsuit?

The lawsuit does not make IUL categorically unsuitable for estate planning. It does make the due diligence bar higher and the carrier selection more consequential.

The estate planning case for IUL rests on the federal estate tax exemption dynamic. The current exemption sits at $13.61 million per individual in 2024. Under the scheduled TCJA sunset, that figure drops to approximately $7 million per individual in 2026. For married couples with estates between $14 million and $27 million, that sunset creates a meaningful estate tax exposure that life insurance held inside an ILIT can address.

The problem the Transamerica lawsuit highlights is counterparty risk. A long-duration insurance contract is only as good as the carrier's willingness and ability to honor its terms. If COI charges are adjustable, and they are in most IUL contracts, the carrier retains meaningful pricing power over the policy's economics throughout its life.

For legal liability protections in irrevocable trusts to function as intended, the underlying policy must remain in force. That requires the trust to have sufficient liquidity to fund premium calls even if those calls increase unexpectedly.

Proper IUL policy structuring can mitigate some of this risk, but it does not eliminate the fundamental issue that adjustable COI charges give the insurer ongoing pricing leverage.

What Are the Best Alternatives to IUL for $5M+ Net Worth Individuals?

If the Transamerica lawsuit has prompted you to reassess your IUL position, here is a concrete menu of alternatives. Each has a different risk profile, cost structure, and use case.

Private Placement Life Insurance deserves particular attention. It is largely unknown outside the ultra-high-net-worth market, but it achieves similar tax-free accumulation goals to retail IUL with greater transparency and materially lower fees. The investment options are customizable, and the cost structure is negotiated rather than embedded in an opaque product chassis.

For policyholders considering exiting an existing Transamerica IUL, IRC Section 1035 allows a tax-free exchange into another life insurance policy or annuity. This avoids triggering a taxable event on accumulated gains. The IUL surrender charges and exit costs are the primary friction point, particularly in the first fifteen policy years.

Comparing IUL against annuities is worth doing before executing any 1035 exchange, as the tax treatment and liquidity profiles differ materially.

How to Audit Your Existing IUL Policy Right Now

Do not wait for the Transamerica litigation to resolve. The audit process is straightforward and should take your advisor or a fee-only insurance analyst a few hours.

Step 1: Request a current in-force illustration. Ask the carrier for a projection using current COI rates and current cap/participation rates, not the rates in effect when you purchased. Run it to age 85 and age 90.

Step 2: Compare to your original illustration. If the current projection shows materially different cash values or requires higher premiums to maintain the death benefit, you have a quantified gap to work with.

Step 3: Identify your purchase date relative to AG 49-A. If you purchased before March 1, 2020, your original illustration was generated under pre-AG 49-A standards. That is a concrete basis for discussing policy restructuring or potential legal standing with an insurance attorney.

Step 4: Review your ILIT's premium funding capacity. If the policy is held in trust, confirm the trust has sufficient assets or funding mechanisms to absorb COI increases without triggering a lapse. Model a scenario where COI charges increase 20–30% from current levels.

Step 5: Get an independent opinion. The original issuing agent has a conflict of interest in this assessment. A fee-only actuary or independent insurance analyst has no commission stake in the outcome.

The tax implications of life insurance payouts are also worth reviewing with your tax attorney before making any structural changes, particularly if your policy has significant accumulated cash value.

For context on how other carriers' products compare on these dimensions, North American IUL product reviews provide a useful benchmark.

What Comes Next for the Transamerica IUL Lawsuit and the Broader IUL Market

The Transamerica case is still in active litigation. No final settlement has been publicly announced. The discovery phase, expert testimony on actuarial assumptions and illustration practices, and potential settlement negotiations are all ongoing. Complex class actions of this type routinely take years to resolve, and any settlement would require court approval and notification to class members.

The broader regulatory trajectory is clearer. The Insurance Information Institute reports that indexed universal life insurance has been one of the fastest-growing permanent life insurance product categories over the past decade. That growth attracted regulatory attention, and AG 49-A was the first significant response. Further tightening of illustration standards is likely, particularly if the Transamerica case produces discovery documents that reveal industry-wide illustration practices.

For the navigating complex financial product litigation context, the Transamerica case fits a pattern: a complex product with opaque pricing, aggressive sales practices during a bull market, and a regulatory framework that lagged the product's growth. The litigation is as much a symptom of that pattern as it is a cause of change.

If you hold a Transamerica IUL policy, the most productive near-term action is the audit described above, not waiting to see whether you qualify for class membership. The class action, if successful, will likely produce modest per-policyholder compensation relative to the actual economic harm from an underperforming policy. Your leverage is in restructuring, exchanging, or exiting the policy on terms that work for your estate plan, not in a class settlement check.

References

• National Association of Insurance Commissioners (NAIC) -- "Indexed Universal Life Insurance Illustration Regulation and Model Actuarial Guideline 49-A" (2020).

• U.S. Securities and Exchange Commission (SEC) -- "Investor Bulletin: Indexed Universal Life Insurance" (2018).

• American Bar Association / Cornell Law School -- "Class Action Fairness Act of 2005, 28 U.S.C. § 1332(d)" (2005).

• Internal Revenue Service -- "IRC Section 7702: Life Insurance Contract Defined."

• Journal of Financial Planning -- "The Use of Life Insurance in the High-Net-Worth Market" (2019).

• FINRA -- "Regulatory Notice 16-32: Suitability Obligations for Complex Products" (2016).

• Insurance Information Institute (III) -- "Life Insurance Fact Book" (2023).

• Society of Actuaries -- "Report on the Lapse and Mortality Experience of Post-Level Premium Period Term Plans" (2014).